Herlinde Dumez

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.

Sigrid Stroobants, O. S. Nielsen, Sasa Dimitrijevic, 2002, European journal of cancer.

Human Red Blood Cells: Rheological Aspects, Uptake, and Release of Cytotoxic Drugs

Gunther Guetens, Ernst A de Bruijn, E. D. de Bruijn, 2004, Critical reviews in clinical laboratory sciences.

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

J. Verweij, A. Oosterom, J. Drevs, 2003 .

Using Pharmacokinetic and Pharmacodynamic Data in Early Decision Making Regarding Drug Development: A Phase I Clinical Trial Evaluating Tyrosine Kinase Inhibitor, AEE788

Patrick Schöffski, Alain C. Mita, Josep Tabernero, 2012, Clinical Cancer Research.